TreeWAS – Variant ID: rs1122979

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
Z50.1 Other physical therapy	0.000	0.861	0.139
N18 Chronic renal failure	0.084	0.916	0.000
N18.3 Chronic kidney disease, stage 3	0.079	0.921	0.000
N18.0 End-stage renal disease	0.079	0.921	0.000
N18.8 Other chronic renal failure	0.078	0.922	0.000
N18.4 Chronic kidney disease, stage 4	0.077	0.923	0.000
N18.2 Chronic kidney disease, stage 2	0.075	0.925	0.000
N18.5 Chronic kidney disease, stage 5	0.073	0.927	0.000
N18.1 Chronic kidney disease, stage 1	0.060	0.940	0.000
N18.9 Chronic renal failure, unspecified	0.033	0.967	0.000
K91.8 Other postprocedural disorders of digestive system, not elsewhere classified	0.000	0.969	0.031
K91 Postprocedural disorders of digestive system, not elsewhere classified	0.000	0.971	0.029
K91.4 Colostomy and enterostomy malfunction	0.000	0.972	0.028
K91.0 Vomiting following gastro-intestinal surgery	0.000	0.976	0.024
K91.3 Postoperative intestinal obstruction	0.000	0.977	0.023
K91.1 Postgastric surgery syndromes	0.000	0.979	0.021
K91.5 Postcholecystectomy syndrome	0.000	0.979	0.021
K91.2 Postsurgical malabsorption, not elsewhere classified	0.000	0.979	0.021
K91.9 Postprocedural disorder of digestive system, unspecified	0.000	0.980	0.020
N17-N19 Renal failure	0.019	0.981	0.000
Z50 Care involving use of rehabilitation procedures	0.000	0.983	0.017
Z50.7 Occupational therapy and vocational rehabilitation, not elsewhere classified	0.000	0.984	0.016
Z50.4 Psychotherapy, not elsewhere classified	0.000	0.986	0.014
Z50.5 Speech therapy	0.000	0.986	0.013
Z50.6 Orthoptic training	0.000	0.987	0.012
Z50.3 Drug rehabilitation	0.000	0.987	0.012
N17 Acute renal failure	0.012	0.988	0.000
N19 Unspecified renal failure	0.010	0.990	0.000
N17.8 Other acute renal failure	0.010	0.990	0.000
N17.0 Acute renal failure with tubular necrosis	0.009	0.991	0.000
N17.2 Acute renal failure with medullary necrosis	0.009	0.991	0.000
N17.1 Acute renal failure with acute cortical necrosis	0.009	0.991	0.000
I34.0 Mitral (valve) insufficiency	0.000	0.992	0.008
Z50.2 Alcohol rehabilitation	0.000	0.992	0.008
Z50.8 Care involving use of rehabilitation procedures	0.000	0.992	0.008
M05.99 Seropositive rheumatoid arthritis, unspecified (Site unspecified)	0.000	0.993	0.007
T43.2 Other and unspecified antidepressants	0.007	0.993	0.000
S82.60 Fracture of lateral malleolus (closed)	0.000	0.993	0.007
M05.90 Seropositive rheumatoid arthritis, unspecified (Multiple sites)	0.000	0.994	0.006
M05.9 Seropositive rheumatoid arthritis, unspecified	0.000	0.994	0.006
Z50.0 Cardiac rehabilitation	0.000	0.994	0.006
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.006	0.994	0.000
T39.1 4-Aminophenol derivatives	0.005	0.995	0.000
I34.1 Mitral (valve) prolapse	0.000	0.995	0.005
Z50.9 Care involving use of rehabilitation procedure, unspecified	0.000	0.995	0.005
I34 Nonrheumatic mitral valve disorders	0.000	0.995	0.005
G99.2 Myelopathy in diseases classified elsewhere	0.005	0.995	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.005	0.995	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.005	0.995	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.005	0.995	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.005	0.995	0.000
I69.3 Sequelae of cerebral infarction	0.000	0.995	0.005
T43.5 Other and unspecified antipsychotics and neuroleptics	0.005	0.995	0.000
K63.5 Polyp of colon	0.000	0.995	0.005
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.005	0.995	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.005	0.995	0.000
T45.0 Antiallergic and antiemetic drugs	0.005	0.995	0.000
M05.98 Seropositive rheumatoid arthritis, unspecified (Other)	0.000	0.995	0.005
M05.96 Seropositive rheumatoid arthritis, unspecified (Lower leg)	0.000	0.995	0.005
M05.95 Seropositive rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.000	0.995	0.005
M05.94 Seropositive rheumatoid arthritis, unspecified (Hand)	0.000	0.995	0.005
M05.93 Seropositive rheumatoid arthritis, unspecified (Forearm)	0.000	0.995	0.005
M05.92 Seropositive rheumatoid arthritis, unspecified (Upper arm)	0.000	0.995	0.005
M05.91 Seropositive rheumatoid arthritis, unspecified (Shoulder region)	0.000	0.995	0.005
M05.97 Seropositive rheumatoid arthritis, unspecified (Ankle and foot)	0.000	0.995	0.004
T43.6 Psychostimulants with abuse potential	0.004	0.996	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.004	0.996	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.004	0.996	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.004	0.996	0.000
R02 Gangrene, not elsewhere classified	0.000	0.996	0.004
I69 Sequelae of cerebrovascular disease	0.000	0.996	0.004
T43.9 Psychotropic drug, unspecified	0.004	0.996	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.004	0.996	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.004	0.996	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.004	0.996	0.000
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction	0.000	0.996	0.004
T43.3 Phenothiazine antipsychotics and neuroleptics	0.004	0.996	0.000
T45.5 Anticoagulants	0.004	0.996	0.000
I77.6 Arteritis, unspecified	0.000	0.996	0.004
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.004	0.996	0.000
I34.8 Other nonrheumatic mitral valve disorders	0.000	0.996	0.004
T37.8 Other specified systemic anti-infectives and antiparasitics	0.004	0.996	0.000
O36.0 Maternal care for rhesus isoimmunisation	0.004	0.996	0.000
T45.2 Vitamins, not elsewhere classified	0.004	0.996	0.000
M54.37 Sciatica (Lumbosacral region)	0.004	0.996	0.000
I69.1 Sequelae of intracerebral haemorrhage	0.000	0.996	0.004
T39.4 Antirheumatics, not elsewhere classified	0.004	0.996	0.000
T39.2 Pyrazolone derivatives	0.004	0.996	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.004	0.996	0.000
T45.8 Other primarily systemic and haematological agents	0.004	0.996	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.004	0.996	0.000
T45.6 Fibrinolysis-affecting drugs	0.004	0.996	0.000
T45.4 Iron and its compounds	0.004	0.996	0.000
T45.3 Enzymes, not elsewhere classified	0.004	0.996	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.004	0.996	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.004	0.996	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.004	0.996	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.004	0.996	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.004	0.996	0.000
K62.3 Rectal prolapse	0.000	0.996	0.004
S82.6 Fracture of lateral malleolus	0.000	0.996	0.004
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.004	0.996	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.004	0.996	0.000
T46.7 Peripheral vasodilators	0.004	0.996	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.004	0.996	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.004	0.996	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.004	0.996	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.004	0.996	0.000
I34.9 Nonrheumatic mitral valve disorder, unspecified	0.000	0.996	0.004
I69.8 Sequelae of other and unspecified cerebrovascular diseases	0.000	0.996	0.004
I34.2 Nonrheumatic mitral (valve) stenosis	0.000	0.996	0.003
T46.1 Calcium-channel blockers	0.003	0.996	0.000
T36 Poisoning by systemic antibiotics	0.003	0.996	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.004	0.996	0.000
G62.9 Polyneuropathy, unspecified	0.003	0.997	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.003	0.997	0.000
T37.5 Antiviral drugs	0.003	0.997	0.000
T37.4 Anthelminthics	0.003	0.997	0.000
T37.3 Other antiprotozoal drugs	0.003	0.997	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.003	0.997	0.000
T37.1 Antimycobacterial drugs	0.003	0.997	0.000
T37.0 Sulphonamides	0.003	0.997	0.000
O36 Maternal care for other known or suspected foetal problems	0.003	0.997	0.000
M54.39 Sciatica (Site unspecified)	0.003	0.997	0.000
I69.2 Sequelae of other nontraumatic intracranial haemorrhage	0.000	0.997	0.003
T47.1 Other antacids and anti-gastric-secretion drugs	0.003	0.997	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.003	0.997	0.000
I69.0 Sequelae of subarachnoid haemorrhage	0.000	0.997	0.003
T39.0 Salicylates	0.003	0.997	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.003	0.997	0.000
O36.3 Maternal care for signs of foetal hypoxia	0.003	0.997	0.000
O36.8 Maternal care for other specified foetal problems	0.003	0.997	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.003	0.997	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
T47.7 Emetics	0.003	0.997	0.000
T47.6 Antidiarrhoeal drugs	0.003	0.997	0.000
T47.5 Digestants	0.003	0.997	0.000
T47.4 Other laxatives	0.003	0.997	0.000
T47.3 Saline and osmotic laxatives	0.003	0.997	0.000
T47.2 Stimulant laxatives	0.003	0.997	0.000
T47.0 Histamine H(2)-receptor antagonists	0.003	0.997	0.000
K51.9 Ulcerative colitis, unspecified	0.000	0.997	0.003
I77.1 Stricture of artery	0.000	0.997	0.003
O36.9 Maternal care for foetal problem, unspecified	0.003	0.997	0.000
O36.1 Maternal care for other isoimmunisation	0.003	0.997	0.000
D51.0 Vitamin B12 deficiency anaemia due to intrinsic factor deficiency	0.000	0.997	0.003
T38.9 Other and unspecified hormone antagonists	0.003	0.997	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.003	0.997	0.000
T38.7 Androgens and anabolic congeners	0.003	0.997	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.003	0.997	0.000
T38.5 Other oestrogens and progestogens	0.003	0.997	0.000
T38.4 Oral contraceptives	0.003	0.997	0.000
T38.2 Antithyroid drugs	0.003	0.997	0.000
T38.1 Thyroid hormones and substitutes	0.003	0.997	0.000
T38.0 Glucocorticoids and synthetic analogues	0.003	0.997	0.000
T41.5 Therapeutic gases	0.003	0.997	0.000
T41.4 Anaesthetic, unspecified	0.003	0.997	0.000
T41.3 Local anaesthetics	0.003	0.997	0.000
T41.2 Other and unspecified general anaesthetics	0.003	0.997	0.000
T41.1 Intravenous anaesthetics	0.003	0.997	0.000
T41.0 Inhaled anaesthetics	0.003	0.997	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.003	0.997	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.003	0.997	0.000
T48.5 Anti-common-cold drugs	0.003	0.997	0.000
T48.4 Expectorants	0.003	0.997	0.000
T48.3 Antitussives	0.003	0.997	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.003	0.997	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.003	0.997	0.000
T48.0 Oxytocic drugs	0.003	0.997	0.000
T49.9 Topical agent, unspecified	0.003	0.997	0.000
T49.8 Other topical agents	0.003	0.997	0.000
T49.7 Dental drugs, topically applied	0.003	0.997	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.003	0.997	0.000
T49.5 Ophthalmological drugs and preparations	0.003	0.997	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.003	0.997	0.000
T49.3 Emollients, demulcents and protectants	0.003	0.997	0.000
T49.2 Local astringents and local detergents	0.003	0.997	0.000
T49.1 Antipruritics	0.003	0.997	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.003	0.997	0.000
D17.6 Benign lipomatous neoplasm of spermatic cord	0.000	0.997	0.003
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.003	0.997	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.003	0.997	0.000
S82.61 Fracture of lateral malleolus (open)	0.000	0.997	0.003
M54.3 Sciatica	0.003	0.997	0.000
I77 Other disorders of arteries and arterioles	0.000	0.997	0.003
Z74.0 Reduced mobility	0.003	0.997	0.000
T36.9 Systemic antibiotic, unspecified	0.003	0.997	0.000
T36.8 Other systemic antibiotics	0.003	0.997	0.000
T36.7 Antifungal antibiotics, systemically used	0.003	0.997	0.000
T36.6 Rifamycins	0.003	0.997	0.000
T36.5 Aminoglycosides	0.003	0.997	0.000
T36.4 Tetracyclines	0.003	0.997	0.000
T36.3 Macrolides	0.003	0.997	0.000
T36.2 Chloramphenicol group	0.003	0.997	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.003	0.997	0.000
C02.9 Tongue, unspecified	0.003	0.997	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.003	0.997	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.003	0.997	0.000
T42.3 Barbiturates	0.003	0.997	0.000
T42.2 Succinimides and oxazolidinediones	0.003	0.997	0.000
T42.0 Hydantoin derivatives	0.003	0.997	0.000
S02.60 Fracture of mandible (closed)	0.000	0.997	0.003
R82.9 Other and unspecified abnormal finding in urine	0.003	0.997	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.003	0.997	0.000
I71.2 Thoracic aortic aneurysm, without mention of rupture	0.003	0.997	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.003	0.997	0.000
O36.7 Maternal care for viable foetus in abdominal pregnancy	0.003	0.997	0.000
O36.2 Maternal care for hydrops foetalis	0.003	0.997	0.000
M05 Seropositive rheumatoid arthritis	0.000	0.997	0.003
M54.38 Sciatica (Sacral and sacrococcygeal region)	0.003	0.997	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.003	0.997	0.000
O36.6 Maternal care for excessive foetal growth	0.003	0.997	0.000
T42.1 Iminostilbenes	0.003	0.997	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.002	0.997	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.997	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.997	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.997	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.997	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.997	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.002	0.997	0.000
T44.0 Anticholinesterase agents	0.002	0.997	0.000
T50.8 Diagnostic agents	0.002	0.997	0.000
T50.7 Analeptics and opioid receptor antagonists	0.002	0.997	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.002	0.997	0.000
T50.5 Appetite depressants	0.002	0.997	0.000
T50.4 Drugs affecting uric acid metabolism	0.002	0.997	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.002	0.997	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.002	0.997	0.000
T50.1 Loop [high-ceiling] diuretics	0.002	0.997	0.000
T50.0 Mineralocorticoids and their antagonists	0.002	0.997	0.000
I77.9 Disorder of arteries and arterioles, unspecified	0.000	0.997	0.003
T36.0 Penicillins	0.002	0.997	0.000
T42.4 Benzodiazepines	0.003	0.997	0.000
R82.7 Abnormal findings on microbiological examination of urine	0.003	0.997	0.000
I73.0 Raynaud's syndrome	0.000	0.997	0.003
D17.7 Benign lipomatous neoplasm of other sites	0.000	0.997	0.002
O36.4 Maternal care for intra-uterine death	0.002	0.998	0.000
M48.06 Spinal stenosis (Lumbar region)	0.002	0.998	0.000
M54.35 Sciatica (Thoracolumbar region)	0.002	0.998	0.000
M54.34 Sciatica-Thoracic	0.002	0.998	0.000
M54.33 Sciatica-Cervicothoracic	0.002	0.998	0.000
M54.32 Sciatica-Cervical	0.002	0.998	0.000
M54.31 Sciatica-Occipit-atl-axl	0.002	0.998	0.000
M54.30 Sciatica (Multiple sites in spine)	0.002	0.998	0.000
K62.8 Other specified diseases of anus and rectum	0.000	0.998	0.002
R82 Other abnormal findings in urine	0.002	0.998	0.000
R82.8 Abnormal findings on cytological and histological examination of urine	0.002	0.998	0.000
I77.5 Necrosis of artery	0.000	0.998	0.002
I77.4 Coeliac artery compression syndrome	0.000	0.998	0.002
I77.3 Arterial fibromuscular dysplasia	0.000	0.998	0.002
R44.3 Hallucinations, unspecified	0.002	0.998	0.000
S83.2 Tear of meniscus, current	0.000	0.998	0.002
C02 Malignant neoplasm of other and unspecified parts of tongue	0.002	0.998	0.000
D89.2 Hypergammaglobulinaemia, unspecified	0.002	0.998	0.000
O36.5 Maternal care for poor foetal growth	0.002	0.998	0.000
D17.9 Benign lipomatous neoplasm, unspecified	0.000	0.998	0.002
M05.8 Other seropositive rheumatoid arthritis	0.000	0.998	0.002
M05.3 Rheumatoid arthritis with involvement of other organs and systems	0.000	0.998	0.002
M05.2 Rheumatoid vasculitis	0.000	0.998	0.002
M05.1 Rheumatoid lung disease	0.000	0.998	0.002
M05.0 Felty's syndrome	0.000	0.998	0.002
R09.8 Other specified symptoms and signs involving the circulatory and respiratory systems	0.002	0.998	0.000
K90-K93 Other diseases of the digestive system	0.000	0.998	0.002
S02.10 Fracture of base of skull (closed)	0.002	0.998	0.000
I77.2 Rupture of artery	0.000	0.998	0.002
I77.0 Arteriovenous fistula, acquired	0.000	0.998	0.002
C01 Malignant neoplasm of base of tongue	0.002	0.998	0.000
I73.9 Peripheral vascular disease, unspecified	0.000	0.998	0.002
T84.8 Other complications of internal orthopaedic prosthetic devices, implants and grafts	0.002	0.998	0.000
K83.1 Obstruction of bile duct	0.000	0.998	0.002
S82.50 Fracture of medial malleolus (closed)	0.000	0.998	0.002
I73 Other peripheral vascular diseases	0.000	0.998	0.002
J11.1 Influenza with other respiratory manifestations, virus not identified	0.002	0.998	0.000
M54.36 Sciatica (Lumbar region)	0.002	0.998	0.000
D17.5 Benign lipomatous neoplasm of intra-abdominal organs	0.000	0.998	0.002
K62.1 Rectal polyp	0.000	0.998	0.002
G62 Other polyneuropathies	0.002	0.998	0.000
K62 Other diseases of anus and rectum	0.000	0.998	0.002
R09.2 Respiratory arrest	0.002	0.998	0.000
C11.9 Nasopharynx, unspecified	0.002	0.998	0.000
I77.8 Other specified disorders of arteries and arterioles	0.000	0.998	0.002
R82.6 Abnormal urine levels of substances chiefly nonmedicinal as to source	0.002	0.998	0.000
R82.5 Elevated urine levels of drugs, medicaments and biological substances	0.002	0.998	0.000
R82.4 Acetonuria	0.002	0.998	0.000
R82.3 Haemoglobinuria	0.002	0.998	0.000
R82.2 Biliuria	0.002	0.998	0.000
R82.1 Myoglobinuria	0.002	0.998	0.000
R82.0 Chyluria	0.002	0.998	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.998	0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.002	0.998	0.000
S32.00 Fracture of lumbar vertebra (closed)	0.000	0.998	0.002
R52.2 Other chronic pain	0.000	0.998	0.002
C11 Malignant neoplasm of nasopharynx	0.002	0.998	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.002	0.998	0.000
G62.1 Alcoholic polyneuropathy	0.002	0.998	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.002	0.998	0.000
C09 Malignant neoplasm of tonsil	0.002	0.998	0.000
C02.8 Overlapping lesion of tongue	0.002	0.998	0.000
C02.4 Lingual tonsil	0.002	0.998	0.000
C02.3 Anterior two-thirds of tongue, part unspecified	0.002	0.998	0.000
C02.2 Ventral surface of tongue	0.002	0.998	0.000
C02.0 Dorsal surface of tongue	0.002	0.998	0.000
C09.9 Tonsil, unspecified	0.002	0.998	0.000
M90.75 Fracture of bone in neoplastic disease (Pelvic region and thigh)	0.002	0.998	0.000
K62.0 Anal polyp	0.000	0.998	0.002
C12 Malignant neoplasm of pyriform sinus	0.002	0.998	0.000
R44.8 Other and unspecified symptoms and signs involving general sensations and perceptions	0.002	0.998	0.000
K83.8 Other specified diseases of biliary tract	0.000	0.998	0.002
K13.0 Diseases of lips	0.000	0.998	0.002
M05.09 Felty's syndrome (Site unspecified)	0.000	0.998	0.002
M05.08 Felty's syndrome (Other)	0.000	0.998	0.002
M05.07 Felty's syndrome (Ankle and foot)	0.000	0.998	0.002
M05.06 Felty's syndrome (Lower leg)	0.000	0.998	0.002
M05.05 Felty's syndrome (Pelvic region and thigh)	0.000	0.998	0.002
M05.04 Felty's syndrome (Hand)	0.000	0.998	0.002
M05.03 Felty's syndrome (Forearm)	0.000	0.998	0.002
M05.02 Felty's syndrome (Upper arm)	0.000	0.998	0.002
M05.01 Felty's syndrome (Shoulder region)	0.000	0.998	0.002
M05.00 Felty's syndrome (Multiple sites)	0.000	0.998	0.002
M05.19 Rheumatoid lung disease (Site unspecified)	0.000	0.998	0.002
M05.18 Rheumatoid lung disease (Other)	0.000	0.998	0.002
M05.17 Rheumatoid lung disease (Ankle and foot)	0.000	0.998	0.002
M05.16 Rheumatoid lung disease (Lower leg)	0.000	0.998	0.002
M05.15 Rheumatoid lung disease (Pelvic region and thigh)	0.000	0.998	0.002
M05.14 Rheumatoid lung disease (Hand)	0.000	0.998	0.002
M05.13 Rheumatoid lung disease (Forearm)	0.000	0.998	0.002
M05.12 Rheumatoid lung disease (Upper arm)	0.000	0.998	0.002
M05.11 Rheumatoid lung disease (Shoulder region)	0.000	0.998	0.002
M05.10 Rheumatoid lung disease (Multiple sites)	0.000	0.998	0.002
M05.29 Rheumatoid vasculitis (Site unspecified)	0.000	0.998	0.002
M05.28 Rheumatoid vasculitis (Other)	0.000	0.998	0.002
M05.27 Rheumatoid vasculitis (Ankle and foot)	0.000	0.998	0.002
M05.26 Rheumatoid vasculitis (Lower leg)	0.000	0.998	0.002
M05.25 Rheumatoid vasculitis (Pelvic region and thigh)	0.000	0.998	0.002
M05.24 Rheumatoid vasculitis (Hand)	0.000	0.998	0.002
M05.23 Rheumatoid vasculitis (Forearm)	0.000	0.998	0.002
M05.22 Rheumatoid vasculitis (Upper arm)	0.000	0.998	0.002
M05.21 Rheumatoid vasculitis (Shoulder region)	0.000	0.998	0.002
M05.20 Rheumatoid vasculitis (Multiple sites)	0.000	0.998	0.002
M05.39 Rheumatoid arthritis with involvement of other organs and systems (Site unspecified)	0.000	0.998	0.002
M05.38 Rheumatoid arthritis with involvement of other organs and systems (Other)	0.000	0.998	0.002
M05.37 Rheumatoid arthritis with involvement of other organs and systems (Ankle and foot)	0.000	0.998	0.002
M05.36 Rheumatoid arthritis with involvement of other organs and systems (Lower leg)	0.000	0.998	0.002
M05.35 Rheumatoid arthritis with involvement of other organs and systems (Pelvic region and thigh)	0.000	0.998	0.002
M05.34 Rheumatoid arthritis with involvement of other organs and systems (Hand)	0.000	0.998	0.002
M05.33 Rheumatoid arthritis with involvement of other organs and systems (Forearm)	0.000	0.998	0.002
M05.32 Rheumatoid arthritis with involvement of other organs and systems (Upper arm)	0.000	0.998	0.002
M05.31 Rheumatoid arthritis with involvement of other organs and systems (Shoulder region)	0.000	0.998	0.002
M05.30 Rheumatoid arthritis with involvement of other organs and systems (Multiple sites)	0.000	0.998	0.002
M05.89 Other seropositive rheumatoid arthritis (Site unspecified)	0.000	0.998	0.002
M05.88 Other seropositive rheumatoid arthritis (Other)	0.000	0.998	0.002
M05.87 Other seropositive rheumatoid arthritis (Ankle and foot)	0.000	0.998	0.002
M05.86 Other seropositive rheumatoid arthritis (Lower leg)	0.000	0.998	0.002
M05.85 Other seropositive rheumatoid arthritis (Pelvic region and thigh)	0.000	0.998	0.002
M05.84 Other seropositive rheumatoid arthritis (Hand)	0.000	0.998	0.002
M05.83 Other seropositive rheumatoid arthritis (Forearm)	0.000	0.998	0.002
M05.82 Other seropositive rheumatoid arthritis (Upper arm)	0.000	0.998	0.002
M05.81 Other seropositive rheumatoid arthritis (Shoulder region)	0.000	0.998	0.002
M05.80 Other seropositive rheumatoid arthritis (Multiple sites)	0.000	0.998	0.002
D12.6 Colon, unspecified	0.000	0.998	0.002
K62.6 Ulcer of anus and rectum	0.000	0.998	0.002
K93 Disorders of other digestive organs in diseases classified elsewhere	0.000	0.998	0.002
H01.0 Blepharitis	0.002	0.998	0.000
C02.1 Border of tongue	0.002	0.998	0.000
K62.4 Stenosis of anus and rectum	0.000	0.998	0.002
O42.0 Premature rupture of membranes, onset of labour within 24 hours	0.002	0.998	0.000
C05 Malignant neoplasm of palate	0.002	0.998	0.000
I73.1 Thromboangiitis obliterans [Buerger]	0.000	0.998	0.002
T43.0 Tricyclic and tetracyclic antidepressants	0.001	0.998	0.001
D17 Benign lipomatous neoplasm	0.000	0.998	0.002
R09 Other symptoms and signs involving the circulatory and respiratory systems	0.002	0.998	0.000
S82.5 Fracture of medial malleolus	0.000	0.998	0.002
C06 Malignant neoplasm of other and unspecified parts of mouth	0.002	0.998	0.000
G62.2 Polyneuropathy due to other toxic agents	0.002	0.998	0.000
Z58.1 Exposure to air pollution	0.002	0.998	0.000
C04 Malignant neoplasm of floor of mouth	0.002	0.998	0.000
O16 Unspecified maternal hypertension	0.002	0.998	0.000
I73.8 Other specified peripheral vascular diseases	0.000	0.998	0.002
R09.3 Abnormal sputum	0.002	0.998	0.000
G62.8 Other specified polyneuropathies	0.002	0.998	0.000
C13 Malignant neoplasm of hypopharynx	0.002	0.998	0.000
C08 Malignant neoplasm of other and unspecified major salivary glands	0.002	0.998	0.000
C03 Malignant neoplasm of gum	0.002	0.998	0.000
C00 Malignant neoplasm of lip	0.002	0.998	0.000
C05.9 Palate, unspecified	0.002	0.998	0.000
C11.8 Overlapping lesion of nasopharynx	0.002	0.998	0.000
C11.3 Anterior wall of nasopharynx	0.002	0.998	0.000
C11.2 Lateral wall of nasopharynx	0.002	0.998	0.000
C11.1 Posterior wall of nasopharynx	0.002	0.998	0.000
C11.0 Superior wall of nasopharynx	0.002	0.998	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.001	0.998	0.000
T40.8 Lysergide [LSD]	0.001	0.998	0.000
T40.7 Cannabis (derivatives)	0.001	0.998	0.000
T40.5 Cocaine	0.001	0.998	0.000
T40.3 Methadone	0.001	0.998	0.000
T40.1 Heroin	0.001	0.998	0.000
T40.0 Opium	0.001	0.998	0.000
C09.8 Overlapping lesion of tonsil	0.002	0.998	0.000
C09.1 Tonsillar pillar (anterior) (posterior)	0.002	0.998	0.000
C09.0 Tonsillar fossa	0.002	0.998	0.000
K62.2 Anal prolapse	0.000	0.998	0.002
D17.3 Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites	0.000	0.998	0.002
R09.0 Asphyxia	0.002	0.998	0.000
K83 Other diseases of biliary tract	0.000	0.998	0.002
R44 Other symptoms and signs involving general sensations and perceptions	0.002	0.998	0.000
K83.0 Cholangitis	0.000	0.998	0.002
C06.2 Retromolar area	0.001	0.998	0.000
G62.0 Drug-induced polyneuropathy	0.001	0.998	0.000
K93.8 Disorders of other specified digestive organs in diseases classified elsewhere	0.000	0.998	0.001
K93.1 Megacolon in Chagas' disease	0.000	0.998	0.001
K93.0 Tuberculous disorders of intestines, peritoneum and mesenteric glands	0.000	0.998	0.001
T40.6 Other and unspecified narcotics	0.001	0.998	0.000
K90.4 Malabsorption due to intolerance, not elsewhere classified	0.001	0.998	0.000
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx	0.001	0.998	0.000
C04.9 Floor of mouth, unspecified	0.001	0.998	0.000
C05.8 Overlapping lesion of palate	0.001	0.998	0.000
C05.2 Uvula	0.001	0.998	0.000
C05.1 Soft palate	0.001	0.998	0.000
C05.0 Hard palate	0.001	0.998	0.000
G99 Other disorders of nervous system in diseases classified elsewhere	0.001	0.998	0.000
I71.3 Abdominal aortic aneurysm, ruptured	0.001	0.998	0.000
I79.2 Peripheral angiopathy in diseases classified elsewhere	0.000	0.998	0.001
C10 Malignant neoplasm of oropharynx	0.001	0.998	0.000
S82.51 Fracture of medial malleolus (open)	0.000	0.998	0.001
C04.8 Overlapping lesion of floor of mouth	0.001	0.998	0.000
C04.1 Lateral floor of mouth	0.001	0.998	0.000
C04.0 Anterior floor of mouth	0.001	0.998	0.000
C06.9 Mouth, unspecified	0.001	0.998	0.000
C06.8 Overlapping lesion of other and unspecified parts of mouth	0.001	0.998	0.000
C06.1 Vestibule of mouth	0.001	0.998	0.000
C06.0 Cheek mucosa	0.001	0.998	0.000
Y44.2 Anticoagulants	0.000	0.998	0.002
S02.6 Fracture of mandible	0.000	0.998	0.001
D89 Other disorders involving the immune mechanism, not elsewhere classified	0.001	0.998	0.000
C00.9 Lip, unspecified	0.001	0.998	0.000
C00.8 Overlapping lesion of lip	0.001	0.998	0.000
C00.6 Commissure of lip	0.001	0.998	0.000
C00.5 Lip, unspecified, inner aspect	0.001	0.998	0.000
C00.4 Lower lip, inner aspect	0.001	0.998	0.000
C00.3 Upper lip, inner aspect	0.001	0.998	0.000
C00.2 External lip, unspecified	0.001	0.998	0.000
C00.1 External lower lip	0.001	0.998	0.000
C00.0 External upper lip	0.001	0.998	0.000
C03.9 Gum, unspecified	0.001	0.998	0.000
C03.1 Lower gum	0.001	0.998	0.000
C03.0 Upper gum	0.001	0.998	0.000
C08.9 Major salivary gland, unspecified	0.001	0.998	0.000
C08.8 Overlapping lesion of major salivary glands	0.001	0.998	0.000
C08.1 Sublingual gland	0.001	0.998	0.000
C08.0 Submandibular gland	0.001	0.998	0.000
C13.9 Hypopharynx, unspecified	0.001	0.998	0.000
C13.8 Overlapping lesion of hypopharynx	0.001	0.998	0.000
C13.2 Posterior wall of hypopharynx	0.001	0.998	0.000
C13.1 Aryepiglottic fold, hypopharyngeal aspect	0.001	0.998	0.000
C13.0 Postcricoid region	0.001	0.998	0.000
I74.3 Embolism and thrombosis of arteries of the lower extremities	0.000	0.998	0.001
K62.7 Radiation proctitis	0.000	0.998	0.001
O42.1 Premature rupture of membranes, onset of labour after 24 hours	0.001	0.998	0.000
R41.8 Other and unspecified symptoms and signs involving cognitive functions and awareness	0.000	0.998	0.002
D51 Vitamin B12 deficiency anaemia	0.000	0.998	0.001
L71.9 Rosacea, unspecified	0.001	0.999	0.000
O14.0 Moderate preeclampsia	0.001	0.999	0.000
D61.9 Aplastic anaemia, unspecified	0.001	0.999	0.000
D73.0 Hyposplenism	0.001	0.999	0.000
K83.5 Biliary cyst	0.000	0.999	0.001
K83.4 Spasm of sphincter of Oddi	0.000	0.999	0.001
K83.3 Fistula of bile duct	0.000	0.999	0.001
K83.2 Perforation of bile duct	0.000	0.999	0.001
R44.2 Other hallucinations	0.001	0.999	0.000
U51.1 Previously admitted to a psychiatric hospital of the provider	0.001	0.999	0.000
Z57.3 Occupational exposure to other air contaminants	0.000	0.999	0.001
S82 Fracture of lower leg, including ankle	0.000	0.999	0.001
D04.7 Skin of lower limb, including hip	0.001	0.999	0.000
R44.1 Visual hallucinations	0.001	0.999	0.000
T86.1 Kidney transplant failure and rejection	0.001	0.999	0.000
Z12.8 Special screening examination for neoplasm of other sites	0.001	0.999	0.000
C07 Malignant neoplasm of parotid gland	0.001	0.999	0.000
I79 Disorders of arteries, arterioles and capillaries in diseases classified elsewhere	0.000	0.999	0.001
O42 Premature rupture of membranes	0.001	0.999	0.000
S06.20 Diffuse brain injury (without open intracranial wound)	0.001	0.999	0.000
D89.0 Polyclonal hypergammaglobulinaemia	0.001	0.999	0.000
K42.0 Umbilical hernia with obstruction, without gangrene	0.000	0.999	0.001
C14.8 Overlapping lesion of lip, oral cavity and pharynx	0.001	0.999	0.000
C14.2 Waldeyer's ring	0.001	0.999	0.000
G99.8 Other specified disorders of nervous system in diseases classified elsewhere	0.001	0.999	0.000
G99.1 Other disorders of autonomic nervous system in other diseases classified elsewhere	0.001	0.999	0.000
K07.6 Temporomandibular joint disorders	0.000	0.999	0.001
K92.0 Haematemesis	0.001	0.999	0.000
I71 Aortic aneurysm and dissection	0.001	0.999	0.001
M25.87 Other specified joint disorders (Ankle and foot)	0.001	0.999	0.000
M25.85 Other specified joint disorders (Pelvic region and thigh)	0.001	0.999	0.000
M87.98 Osteonecrosis, unspecified (Other)	0.001	0.999	0.000
C10.8 Overlapping lesion of oropharynx	0.001	0.999	0.000
C10.4 Branchial cleft	0.001	0.999	0.000
C10.3 Posterior wall of oropharynx	0.001	0.999	0.000
C10.2 Lateral wall of oropharynx	0.001	0.999	0.000
C10.1 Anterior surface of epiglottis	0.001	0.999	0.000
C10.0 Vallecula	0.001	0.999	0.000
D09.0 Bladder	0.001	0.999	0.000
D22.6 Melanocytic naevi of upper limb, including shoulder	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations